Registry of Lobbyists
BIOTECANADA
Subject Matter: Retrospective: | INTELLECTUAL PROPERTY POLICY FOR BIOTECHNOLOGY INCLUDING DATA PROTECTION; PATENTED MEDICINE PRICES REVIEW BOARD (PMPRB) PRICE REVIEW ISSUES; REGULATORY EFFICIENCIES INCLUDING Cost recovery initiative, REVIEW TIMES, orphan product strategy; PROGRESSIVE LICENSING FRAMEWORK; NATIONAL PHARMACEUTICAL STRATEGY; WORLD TRADE ORGANIZATION (WTO) ISSUES: Access & benefit sharing, TRIPS AGREEMENT, DISPUTE RESOLUTION; CANADIAN ENVIRONMENT PROTECTION ACT AND REGULATIONS; FOOD AND DRUGS ACT AND REGULATIONS; SUBMISSION REVIEW PROCESS FOR BIOLOGICS; FOOD LABELLING; SCIENTIFIC RESEARCH & EXPERIMENTAL DEVELOPMENT (SR&ED) TAX CREDIT PROGRAM; TAX REVIEW OF LIMITED LIABILITY CORPORATIONS; Science & rechnology strategy |
Subject Matter: Prospective: | NATIONAL BIOTECH WEEK; BIOTECH AWARENESS (CAUCUS) EFFORTS OF PARLIAMENTARIANS; IMPROVED TAXATION FRAMEWORK for SR&ED; REGULATORY IMPROVEMENTS; ORPHAN PRODUCT POLICIES; CANADIAN science & technology STRATEGY / INNOVATION AGENDA; INTELLECTUAL PROPERTY/PATENT POLICY AND REGULATIONS; PMPRB PRICE REVIEW ISSUES; WTO ISSUES, ACCESS & BENEFIT SHARING: TRIPS AGREEMENT; CANADIAN ENVIRONMENTAL PROTECTION ACT AND REGULATIONS; HEALTH CANADA: FOOD AND DRUGS ACT AND REGULATIONS, SUBMISSION REVIEW PROCESS FOR BIOLOGICS, COST RECOVERY REVIEW; REGULATORY APPROVAL PROCESS FOR PLANTS WITH NOVEL TRAITS; SR&ED TAX CREDIT PROGRAM; BIOSAFETY PROTOCOL; ADVENTITIOUS PRESCENCE POLICY; ACCOUNTABILITY FOR CADTH/CDR |
Categories | Description |
---|---|
Policy or Program | ACCESS & BENEFIT SHARING: TRIPS AGREEMENT |
Regulation | ACCESS TO MEDICINES REGIME |
Policy or Program | ADVENTITIOUS PRESCENCE POLICY |
Policy or Program | BIOSAFETY PROTOCOL |
Policy or Program | CANADIAN BIOTECHNOLOGY STRATEGY / INNOVATION AGENDA / SCIENCE & TECHNOLOGY STRATEGY |
Regulation, Bill or Resolution | CANADIAN ENVIRONMENTAL PROTECTION ACT AND REGULATIONS |
Policy or Program | Creation of a modern regulatory environment, recognition of international standards and reviews, and establishing clarity on data ownership for intellectual property |
Policy or Program | Establish accountability with the federally financed Canadian Agency for Drugs and Technologies and Health (CADTH) and its Common Drug Review process (Health Canada) |
Regulation | FOOD AND DRUGS ACT AND REGULATIONS |
Policy or Program | IMPROVED TAXATION FRAMEWORK |
Policy or Program | IMPROVEMENTS TO THE SR&ED TAX CREDITS |
Regulation, Policy or Program | INTELLECTUAL PROPERTY/PATENT POLICY AND REGULATIONS |
Policy or Program | NOVEL FOODS AND FOOD LABELLING |
Policy or Program | ORPHAN PRODUCT POLICIES |
Policy or Program | PATENTED MEDECINES PRICES REVIEW BOARD (PMPRB) PRICE REVIEW |
Regulation, Policy or Program | REGULATORY APPROVAL PROCESS FOR PLANTS WITH NOVEL TRAITS |
Policy or Program | SUBMISSION REVIEW PROCESS FOR BIOLOGICS, COST RECOVERY REVIEW |
Policy or Program | Support for capital formation including tax law recognition of Limited Liability Corporations (LLCs) |
Policy or Program | WORLD TRADE ORGANIZATION (WTO) ISSUES |